Utilization and Expenditure on Blood Glucose Test Strips in Canada

Cameron, Chris; Virani, Adil; Dean, Heather; Evans, Mike; Dolovich, Lisa; Dahl, Marshall

doi:10.1016/s1499-2671(10)41008-4

Cited by 14 publications

(21 citation statements)

References 18 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…However, partly due to the increase in medical cost, higher frequency SMBG often is not recommended, especially for insulin-naïve diabetes patients (Tunis et al, 2010b;Cameron et al, 2010a). In addition, lower frequency SMBG, for example once daily, may not be useful for glycemic control (Malanda et al, 2012;Farmer ete al., 2012;Clar et al, 2010).…”

Section: Discussionmentioning

confidence: 99%

“…(American Diabetes Association, 2016). In Canada, $247 million were spent on blood glucose test strips by publicly funded drug programs in 8 Canadian provinces (Cameron et al, 2010a). An incremental cost of $113,643 per quality-adjusted life-year gained was identified for insulin-naïve type 2 diabetes patients using 7 strips per week compared with no testing (Cameron et al, 2010b).…”

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Effects of structured testing versus routine testing of blood glucose in diabetes self-management: A randomized controlled trial

Nishimura

Harashima

Fujita

et al. 2017

Journal of Diabetes and its Complications

View full text Add to dashboard Cite

Aims:To compare the effects of structured and routine testing regimens used in self-monitoring of blood glucose (SMBG) on glycemic control and diabetes self-management in insulin-naïve type 2 diabetes patients. Methods:Sixty-two outpatients with insulin-naïve type 2 diabetes were randomly allocated into two less-frequent SMBG usage groups: a structured testing group (STG) and a routine testing group (RTG). Subjects in STG measured 7-points on SMBG for 3 consecutive days once every two months without daily testing; subjects in RTG measured SMBG 3 times each week before breakfast on Monday and Friday and before dinner on Wednesday. The primary endpoint was HbA1c reduction. The secondary endpoints were change in body weight, blood pressure, treatment change, and self-management performance change. Results:HbA1c levels were significantly decreased by 0.32% (3.50 mmol/mol) in STG, partly because physicians changed medications more actively. In contrast, body weight and systolic/diastolic blood pressure were significantly reduced by 0.94 kg and 6.8/4.7 mmHg, respectively, in RTG, possibly related to the increased diet and exercise score in RTG. Conclusions:Structured testing without daily testing is beneficial for glycemic control; routine testing 3 times a week is more helpful for daily self-management. In low SMBG frequency usage, these two regimens can be utilized according to individual diabetic conditions.

show abstract

Section: Discussionmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

Effects of structured testing versus routine testing of blood glucose in diabetes self-management: A randomized controlled trial

Nishimura

Harashima

Fujita

et al. 2017

Journal of Diabetes and its Complications

View full text Add to dashboard Cite

show abstract

“…People with diabetes are asked to perform SMBG, manage multiple medications, maintain foot hygiene, adhere to diet and meal plans, and engage in exercise programs [9]. While for some insulin users SMBG is an important component of diabetes care, it poses a significant inconvenience/burden on the patient, in addition to the significant and well-documented economic costs [10–13]. …”

Section: Introductionmentioning

confidence: 99%

Cost of Self-Monitoring of Blood Glucose in Canada among Patients on an Insulin Regimen for Diabetes

et al. 2012

View full text Add to dashboard Cite

IntroductionPeople with diabetes are at a higher risk of developing a variety of medical conditions relative to those without diabetes, resulting in increased healthcare costs. Self-monitoring of blood glucose (SMBG) is accepted as a recommended element of effective diabetes self-management. However, little is known about the real-world frequency and actual expenditures associated with SMBG, as well as the impact of SMBG costs relative to the cost of diabetes treatments. The primary objective is to evaluate the real-world utilization and costs of SMBG tests in Canada among insulin-treated diabetes patients during a 12-month follow-up period.MethodsA retrospective cohort study was conducted using the IMS Brogan Inc. Drug Plan database from July 1, 2006 through June 30, 2010. Total costs during the 12-month follow-up period were assessed, focusing on blood glucose (BG) testing strip costs, insulin therapy costs, and costs associated with oral antidiabetics medications. All prevalent patients with two or more prescriptions for insulin between January 1, 2007 and December 31, 2009 were initially included in the analysis, the first prescription serving as their index date. Depending on the insulin type(s) used, patients were subcategorized into one of four insulin regimen groups (basal, bolus, premix, or basal–bolus).ResultsAmong an initial sample of patients with two or more claims for insulin between January 1, 2007 and December 31, 2009, 142,551 met the aforementioned inclusion and exclusion criteria. An overall mean utilization of pharmacy-based blood glucose testing of approximately 1,094 strips per person per year was observed, with an average cost per testing strip of Canadian $0.79. SMBG treatment costs for insulin users ($860), specifically those associated with prescription testing strips, totaled 41.6% of the average annual pharmacy costs of diabetes-related prescriptions ($2,068).ConclusionThis study shows that SMBG accounts for approximately 40% of the total diabetes-related pharmacy costs for insulin users.

show abstract

“…3 In 2006, $250 million was spent on blood glucose test strips in 8 publicly funded drugs plans in Newfoundland and Labrador, Nova Scotia, Quebec, Ontario, Manitoba, Saskatchewan and British Columbia, while over $120 million was spent in privately funded drug plans in Canada. 4 In some publicly funded drug plans in Canada, blood glucose test strips are among the top 5 classes in terms of total expenditure, 5 with costs exceeding those for all oral antidiabetes drugs combined. 4,6 It is estimated that more than 50% of the total expenditure on blood glucose test strips is for patients with type 2 diabetes who are not using insulin.…”

mentioning

confidence: 99%

“…4 In some publicly funded drug plans in Canada, blood glucose test strips are among the top 5 classes in terms of total expenditure, 5 with costs exceeding those for all oral antidiabetes drugs combined. 4,6 It is estimated that more than 50% of the total expenditure on blood glucose test strips is for patients with type 2 diabetes who are not using insulin. 3 Costs related to test strips are expected to rise steadily 5,7 because of the increasing prevalence of type 2 diabetes.…”

mentioning

confidence: 99%

Cost-effectiveness of self-monitoring of blood glucose in patients with type 2 diabetes mellitus managed without insulin

Cameron¹,

Coyle²,

Ur³

et al. 2009

Canadian Medical Association Journal

View full text Add to dashboard Cite

Utilization and Expenditure on Blood Glucose Test Strips in Canada

Cited by 14 publications

References 18 publications

Effects of structured testing versus routine testing of blood glucose in diabetes self-management: A randomized controlled trial

Effects of structured testing versus routine testing of blood glucose in diabetes self-management: A randomized controlled trial

Cost of Self-Monitoring of Blood Glucose in Canada among Patients on an Insulin Regimen for Diabetes

Cost-effectiveness of self-monitoring of blood glucose in patients with type 2 diabetes mellitus managed without insulin

Contact Info

Product

Resources

About